Evaluation of Endocrine Related Adverse Effects of Non-Endocrine Targeted Pharmaceuticals in Cellular Systems
CONCLUSION: Present data suggest that all tested pharmaceuticals may have potential endocrine disrupting effect, which should be considered when used in pregnancy.PMID:36843259 | DOI:10.2174/1871530323666230224145624
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - Category: Endocrinology Authors: Bita Entezari Deniz Bozdag Hande Gurer-Orhan Source Type: research
More News: Endocrinology | Estradiol | Hormones | Indomethacin | Pantoprazole | Pregnancy | Protonix